Next Article in Journal
Oxygenated Polyketides from Plakinastrella mamillaris as a New Chemotype of PXR Agonists
Next Article in Special Issue
pH-Dependent Solution Structure and Activity of a Reduced Form of the Host-Defense Peptide Myticin C (Myt C) from the Mussel Mytilus galloprovincialis
Previous Article in Journal
Nepheliosyne B, a New Polyacetylenic Acid from the New Caledonian Marine Sponge Niphates sp.
Previous Article in Special Issue
Conopeptides from Cape Verde Conus crotchii
Review

Strategies for the Development of Conotoxins as New Therapeutic Leads

Monash Institute of Pharmaceutical Science, Monash University, 381 Royal Parade, Parkville 3052, Australia
*
Author to whom correspondence should be addressed.
Mar. Drugs 2013, 11(7), 2293-2313; https://doi.org/10.3390/md11072293
Received: 14 April 2013 / Revised: 27 May 2013 / Accepted: 6 June 2013 / Published: 28 June 2013
(This article belongs to the Special Issue Marine Peptides and Their Mimetics)
Peptide toxins typically bind to their target ion channels or receptors with high potency and selectivity, making them attractive leads for therapeutic development. In some cases the native peptide as it is found in the venom from which it originates can be used directly, but in many instances it is desirable to truncate and/or stabilize the peptide to improve its therapeutic properties. A complementary strategy is to display the key residues that make up the pharmacophore of the peptide toxin on a non-peptidic scaffold, thereby creating a peptidomimetic. This review exemplifies these approaches with peptide toxins from marine organisms, with a particular focus on conotoxins. View Full-Text
Keywords: peptide toxin; peptidomimetic; ion channel; pain; cone snail peptide toxin; peptidomimetic; ion channel; pain; cone snail
Show Figures

Graphical abstract

MDPI and ACS Style

Brady, R.M.; Baell, J.B.; Norton, R.S. Strategies for the Development of Conotoxins as New Therapeutic Leads. Mar. Drugs 2013, 11, 2293-2313. https://doi.org/10.3390/md11072293

AMA Style

Brady RM, Baell JB, Norton RS. Strategies for the Development of Conotoxins as New Therapeutic Leads. Marine Drugs. 2013; 11(7):2293-2313. https://doi.org/10.3390/md11072293

Chicago/Turabian Style

Brady, Ryan M., Jonathan B. Baell, and Raymond S. Norton 2013. "Strategies for the Development of Conotoxins as New Therapeutic Leads" Marine Drugs 11, no. 7: 2293-2313. https://doi.org/10.3390/md11072293

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop